In human adipose-derived stem cells, megestrol acetate increased the proliferation-associated CCK-8 readout at 10 μM after 48 h. A separate GR knockdown experiment attenuated MA-stimulated proliferation compared with control siRNA, supporting GR involvement. Cells were sourced from two women; donor-level reproducibility and an in-vivo regenerative benefit were not established. [2]
PR-regulated transcription in T47D cells
Cell-based study · T47D human breast cancer cells, charcoal-stripped serum medium for 48 h before treatment [1]
MA increased FKBP5 and E2F1 transcript abundance relative to ethanol vehicle. R5020 served as a progesterone-agonist control. This is a functional transcription assay; it does not establish binding affinity, an EC50, or receptor exclusivity.
Literature-Reported Treatment Conditions
- Treatment concentration
- MA 100 nM; positive control R5020 10 nM
- Exposure duration
- 8 h
- Method
- Cell treatment followed by TaqMan real-time PCR; expression normalized to ethanol-treated cells
- Vehicle
- Ethanol
- Co-treatment
- None in the selected MA arm
- Reported limits
- Ethanol percentage and biological independence of triplicate determinations are not specified in the selected assay description. SD versus SE labeling is inconsistent; no ± estimate is adopted.
Methods and source locations
Compound reported in the paper: Megestrol acetate; Compound label in the paper: MA
Experimental findings for the named acetate form; no equivalence to an Adooq lot or clinical formulation is established.
Methods: Chemicals and reagents; Progesterone receptor (PR) activity; Data analysis. Results: MA activity on the PR; Figure 6B–C.
FKBP5 and E2F1 transcript abundance relative to ethanol vehicle: TaqMan real-time PCR; Figure 6B–C marks both MA comparisons **p<0.01 versus vehicle — Results: MA activity on the PR, reported means; Figure 6B–C and caption; Methods: PR activity
GR-associated transcription in MDA-MB-231 cells
Cell-based study · MDA-MB-231 human triple-negative breast cancer cells; 2.5% charcoal-stripped FCS conditioning for 48 h [1]
MA increased SGK1 and GILZ transcript abundance in an assay using dexamethasone as positive control. The endpoints support glucocorticoid-like transcriptional activity in this model, without establishing receptor selectivity or an antitumor effect.
Literature-Reported Treatment Conditions
- Treatment concentration
- MA 1 μM; positive control dexamethasone 0.1 μM
- Exposure duration
- 4 h
- Method
- Cell treatment and quantitative real-time PCR, GR target expression normalized to β-actin
- Vehicle
- Ethanol
- Co-treatment
- None in the selected MA arm
- Reported limits
- Final ethanol percentage and biological independence of triplicate determinations are not specified; Figure 8 supplies no numerical error estimates.
Methods and source locations
Compound reported in the paper: Megestrol acetate; Compound label in the paper: MA
Experimental findings for the named acetate form; no equivalence to an Adooq lot or clinical formulation is established.
Methods: Chemicals and reagents; Glucocorticoid receptor (GR) activity. Results: MA activity on the GR; Figure 8A–B.
SGK1 and GILZ transcript abundance relative to vehicle: Quantitative real-time PCR; numerical means from Results, not estimated from plotted bars — Results: MA activity on the GR; Figure 8A–B and caption; Methods: GR activity
Proliferation-associated response in human ASCs
Cell-based study · Human adipose-derived stem cells obtained from subcutaneous liposuction samples from two healthy women [2]
MA 10 μM increased the proliferation-associated CCK-8 readout versus no MA in human ASCs. This endpoint is a colorimetric proxy, not direct division tracking.
Literature-Reported Treatment Conditions
- Treatment concentration
- MA 10 μM (selected comparison; Figure 1A also tests 1, 5 and 50 μM)
- Exposure duration
- 48 h
- Method
- 0.2% FBS culture; CCK-8 proliferation assay
- Co-treatment
- None in the selected comparison
- Reported limits
- MA stock solvent, final vehicle concentration, supplier and lot are not specified in the acquired main text. No exact proliferation means or error estimates are extracted from bars.
Methods and source locations
Compound reported in the paper: Megestrol acetate; Compound label in the paper: MA
Experimental findings for the named acetate form; no equivalence to an Adooq lot or clinical formulation is established.
Methods: Cell Culture; Cell Proliferation Assay; Statistical Analysis. Results: Progesterone and MA Increased the Proliferation and Migration of ASCs; Figure 1A.
Proliferation-associated CCK-8 readout: CCK-8, 48 h; 450 nm absorbance — Methods: Cell Proliferation Assay; Results: Progesterone and MA Increased the Proliferation and Migration of ASCs; Figure 1A
GR knockdown validation of MA-stimulated ASC proliferation
Cell-based study · Human adipose-derived stem cells obtained from subcutaneous liposuction samples from two healthy women [2]
GR-targeting siRNA reduced GR mRNA and attenuated MA-stimulated proliferation compared with control siRNA. The MA concentration for Figure 6B is not explicitly specified in its caption or associated Results, so the validation is not assigned the 10 μM dose used in the separate Figure 1A comparison.
Literature-Reported Treatment Conditions
- Treatment concentration
- GR siRNA 50 nM; MA concentration for Figure 6B not explicitly specified
- Exposure duration
- siRNA transfection: 24 h; proliferation assay method specifies MA exposure for 48 h
- Method
- siGR#1 versus control siRNA; GR mRNA knockdown assessed by qPCR; CCK-8 proliferation assay
- Co-treatment
- MA with GR-targeting siRNA versus MA with control siRNA in the validation experiment
- Reported limits
- The MA concentration for Figure 6B is not explicitly specified. MA solvent, supplier and lot are not specified in acquired main text. Exact proliferation values are not inferred from bars.
Methods and source locations
Compound reported in the paper: Megestrol acetate; Compound label in the paper: MA
Experimental findings for the named acetate form; no equivalence to an Adooq lot or clinical formulation is established.
Methods: Cell Culture; Cell Proliferation Assay; Small Interfering RNA Transfection; Statistical Analysis. Results: GR Silencing Attenuated MA-Induced Stimulation; Figure 6A–B.
GR knockdown and MA-induced proliferation: qPCR validation of GR knockdown and CCK-8 comparison of siCON/siGR with and without MA; no exact percentages inferred — Methods: Small Interfering RNA Transfection; Results: GR Silencing Attenuated MA-Induced Stimulation; Figure 6A–B